Johnson & Johnson Continue to Overlook Warning Doctors That Prescribe Elmiron

Despite the overwhelming evidence that Elmiron causes permanent, irreversible, and progressive eyesight damage, doctors continue to prescribe the medication

Friday, April 2, 2021 - Doctors continue to prescribe Elmiron (pentosan polysulfate sodium) to treat the pain caused by interstitial cystitis (IC) better known as painful bladder syndrome despite evidence that the drug is little more than a placebo. A recent scientific study confirmed as much when it concluded that only one-third of Johnson & Johnson's miracle drug patients experience more than a 50% reduction of interstitial cystitis pain. That poor performance may account for the fact that Elmiron is the only drug currently FDA approved to treat the mostly female condition. To add injury to insult, women that have taken Elmiron for several years report that the drug allegedly has caused them eyesight damage. Only recently when the company updated the website to read: "Pigment changes in the retina of the eye (also referred to as pigmentary maculopathy in medical journal articles) have been reported with long-term use of ELMIRON. While the cause of the pigmentary changes is unclear, continued long-term dosing with ELMIRON may be a risk factor. The consequences of these pigmentary changes in the retina are not fully understood." Hundreds of women have filed lawsuits against Johnson & Johnson for failing to warn them of the dangers that Elmiron posed to their eyesight. If you or a loved one have taken Elmiron to treat IC and have lost the ability to read in sub-optimal lighting conditions, or to see and drive at night, you may wish to speak with an Elmiron Blindness Attorney to see if you qualify to file a claim.

For example, a Kentucky woman filed a lawsuit in January of 2021 that claims taking Elmiron caused her to develop pigmentary maculopathy in both eyes that permanently damaged her vision, among other things. In her lawsuit, the plaintiff alleges that Johnson & Johnson "received no warnings from the manufacturers about the risk of vision damage. Neither did her doctors receive any warnings related to retinal injury. She also received no recommendation from the manufacturer to regularly monitor her vision health while taking the drug. The plaintiff now suffers from severe maculopathy in both eyes." according to NewYorkLegalExaminer. As one can readily ascertain, doctors prescribing Elmiron were also left in the dark by the drug's manufacturer. Johnson & Johnson may have known as early as the late 1980s that Elmiron could cause vision damage but chose not to alert the public.

In another instance, a Texas woman is blaming her legal blindness on taking the anti-IC drug Elmiron. The woman claims that her vision started to blur and trouble seeing dring sub-optimal lighting conditions only two years after starting the daily Elmiron regimen. MedNews365 reports, "Unfortunately, in 2010, doctors determined the patient was legally blind from macular degeneration and in 2013, she was further diagnosed the eye disease pigmentary retina dystrophy, which is typically characterized by colored spots on the retina."

More Recent Elmiron Eye Lawsuit News:

Lawyers for Elmiron Eye Lawsuits

Attorneys handling Elmiron Eye lawsuits for leukemia, non-Hodgkin lymphoma, and multiple myeloma offer free, no-obligation case review for individuals and families who believe they may have grounds to file a Elmiron Eye lawsuit. Working on a contingency basis, these attorneys are committed to never charging legal fees unless they win compensation in your Elmiron Eye lawsuit. The product liability litigators handling Roundup claims at OnderLaw have a strong track record of success in representing families harmed by dangerous drugs and consumer products.